Organisation paid for research Program year 2025 Source: CMS Open Payments

Sunbeam Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$893,681

561 payments

Through program year 2025, Sunbeam Clinical Research LLC is reported as receiving $893,681 in research payments, across 561 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$60,328	8
2022	Research	$25,100	5
2021	Research	$74,620	19
2020	Research	$225,778	44
2019	Research	$507,855	485

Breakdown

Who paid Research payments · program years 2019–2025

Akebia Therapeutics Inc $580,897 530 payments
H. Lundbeck A S $249,057 22 payments
Regeneron Pharmaceuticals, Inc. $47,828 7 payments
Sanofi US Services Inc. $12,500 1 payment
AbbVie, Inc. $3,399 1 payment

Studies the money was for Research payments · program years 2019–2025

Akb-6548-Ci-0014 $345,262 461 payments
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (Ndd-Ckd) (Pro2tect-Correction) $149,042 23 payments
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension RESTORE $139,944 1 payment
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy $109,113 21 payments
Akb-6548-Ci-0014 $52,441 11 payments
Psychometric Evaluation of the Living with Postural Orthostatic Tachycardia Syndrome Questionnaire $47,828 7 payments
Akb-6548-Ci-0015 $19,249 22 payments
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Evaluate the Efficacy and Safety of Dupilumab Therapy in Patients With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype $12,500 1 payment
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (Ndd-Ckd) (Pro2tect-Conversion) $12,122 11 payments
M11-352 $3,399 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.